Sat.Jul 30, 2022 - Fri.Aug 05, 2022

article thumbnail

Should you take a job with a biotech startup?

World of DTC Marketing

At first, the opportunity to join a small biotech startup sounds excellent. Smaller staff usually means less bureaucracy and being on the ground floor of a potentially financially rewarding career. But there are risks. Leaving the comforts of a big company with a calcified infrastructure, laser-focused job roles, well-established SOPs, deeper pockets, and excellent job security for the scramble and chaos of a younger company isn’t for everyone. .

Pharma 242
article thumbnail

Tapping into pharma’s growing opportunities in digital health

Pharmaceutical Technology

Soaring patient numbers are stretching hospital capacity across the globe, forcing healthcare providers and their partners to think laterally about how to meet the demand without doubling their resources. Smarter diagnostic tools and more sophisticated remote- and self-care models will have an increasingly important role to play, as long as any advances are seen to deliver excellent outcomes and a better patient experience.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Who won INVEST PharmaTech Pitch Perfect contest?

MedCity News

At the INVEST PhamaTech conference last month, five startups shared their vision for how they are seeking to reinvent clinical trials as part of the Pitch Perfect contest.

121
121
article thumbnail

Connecting EHR to clinical trials: How to embrace the promise of real-world data

pharmaphorum

We all know that real-world data (RWD) from electronic health records (EHR) could boost clinical trial efficiency and improve patient outcomes – so what’s holding us back? It’s been more than two decades since the ground-breaking potential of using electronic health records (EHR) to inform clinical research was first mooted. Since then, progress has been slow, but the industry now has everything it needs to close the feedback loop between science, evidence, and care, said speakers at a recent Co

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Are online health searches private?

World of DTC Marketing

A Gizmodo investigation into some of the nation’s biggest data brokers found more than two dozen promoting access to datasets containing digital information on millions of pregnant and potentially pregnant people across the country. At least one of those companies also offered an extensive catalog of people using birth control targeted by more restrictive states, But is this true?

Media 205
article thumbnail

Moderna signs contract to supply Covid-19 booster vaccines to the US

Pharmaceutical Technology

Moderna has entered a new supply contract with the US Government to deliver 66 million doses of its Covid-19 vaccine booster candidate, mRNA-1273.222. The contract comprises a $1.74bn award to produce and supply these vaccine doses and options to further procure up to 234 million additional doses of the company’s booster candidates. A bivalent booster candidate, the mRNA-1273.222 vaccine comprises Spikevax along with the Omicron BA.4/5 strain messenger RNA (mRNA).

More Trending

article thumbnail

Bristol Myers Squibb aims to improve disability diversity in clinical trials

European Pharmaceutical Review

Dubbed Disability Diversity in Clinical Trials (DDiCT), the initiative aims to provide recommendations on how to improve access, engagement, speed of enrolment and participation of people with disabilities in clinical trials. The goal is to “ensure all patient groups are reflective of the real-world population and aligned with the epidemiology of the disease studies,” a statement said.

article thumbnail

Sarepta says early filing for DMD gene therapy is back on

pharmaphorum

Sarepta is pressing forward with a bold plan to file with the FDA for accelerated approval of its gene therapy SRP-9001 for Duchenne muscular dystrophy (DMD) in the next few months, with a view to making it available in sometime around the middle of 2023. The US biotech – which already has three antisense drugs for DMD on the market – had said earlier it was planning to delay the application into 2023, so the new announcement marks an acceleration of its plans.

FDA 104
article thumbnail

North America is seeing a hiring boom in pharmaceutical industry machine learning roles

Pharmaceutical Technology

North America extended its dominance for machine learning hiring among pharmaceutical industry companies in the three months ending May. The number of roles in North America made up 63.9% of total machine learning jobs - up from 62.6% in the same quarter last year. That was followed by Europe, which saw a 0.6 year-on-year percentage point change in machine learning roles.

article thumbnail

3 reasons you should use NLP to make sense of SDOH

MedCity News

Obtaining an understanding of how specific SDOH factors affect individuals is extremely difficult because SDOH data is not methodically collected by clinicians.

124
124
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

3 Ways to Build More Trust With Customers

Salesforce

For many companies, being seen as trustworthy by customers is an ultimate goal. But what does it really mean to have trust and build trust with customers? In a recent conversation on the Blazing Trails podcast , marketing guru Seth Godin and Salesforce vice president and global innovation evangelist Brian Solis discussed the issues around trust and how companies can get to know their customers better.

article thumbnail

Roche scores phase 3 win for subcutaneous Tecentriq, eyes filings

pharmaphorum

Roche’s Tecentriq could become the first drug in the PD-1/PD-L1 inhibitor class to be approved in a subcutaneous formulation, after the new version matched the original intravenous formulation in a phase 3 trial. The results of the IMscin001 study found that an injection of Tecentriq under the skin taking just a few minutes was non-inferior to a 30 to 60-minute infusion with the IV version in terms of pharmacokinetics – how the active ingredient behaves in the body after administration.

Marketing 104
article thumbnail

Samsung Biologics, GreenLight conclude Covid-19 vaccine engineering run

Pharmaceutical Technology

Samsung Biologics and GreenLight Biosciences have completed the initial commercial-scale engineering run for their messenger ribonucleic acid (mRNA) Covid-19 vaccine under their manufacturing collaboration. Last year, the companies entered a strategic collaboration. Subsequently, technology transfer as well as scale-up from the lab bench to the commercial facility of Samsung were carried out in a period of seven months.

article thumbnail

Homeward secures $50M, partners with Priority Health for rural value-based care

MedCity News

Homeward is working to fill in the gap of primary and specialty care in rural areas. Currently working in Michigan, it hopes to use the funding to expand into other markets.

Marketing 119
article thumbnail

How to Stay Competitive in the Evolving State of Martech

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

article thumbnail

Generic subscription services like Mark Cuban’s promise cheaper drugs — but will it work?

PharmaVoice

Companies like Cost Plus Drugs and DiRx can bring generics directly to consumers at a fraction of the price, but whether it’s enough to fix the inflated U.S. healthcare system is yet to be seen.

article thumbnail

There Are Many Futures of Work — Which One Are You Creating?

Salesforce

If you’re worried about the ever-changing nature of work and what the future holds for your company, you’re not alone. The long-established social contract between employees and employers is being rewritten on a global scale. One thing is clear – there is not a singular future of work. There will be a variety of futures available to your organization, and you will need to decide which one makes sense, and how to create it.

Retail 98
article thumbnail

Scott Burrows, Motivational Sales Speaker

Scott Burrows

What is Blocking You? As a motivational sales speaker, let me be honest and tell you that beating-up yourself because you didn’t “make your numbers,” probably won’t work. I know that it might be a popular concept, but motivation doesn’t work that way.

Sales 98
article thumbnail

Most Medicare beneficiaries concerned about healthcare cost inflation, survey finds

MedCity News

About 95% of Medicare beneficiaries are anxious about inflation’s impact on healthcare costs, with 45% saying costs have already increased because of inflation, the eHealth survey discovered.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Advancing Health Equity with Data & Analytics: A Q&A with Anikia Nelson, MD

Clarify Health

At the beginning of Dr. Anikia Nelson’s career, she realized she wanted to have an impact beyond the scope of direct patient care. She’s making a big impact here at Clarify Health as our Senior Director of Clinical Product Management. She’s a physician by training and now specializes in driving Clarify’s product strategy and roadmap to enhance clinical nuance, improve actionability and ensure the most impactful use of social determinants of health (SDoH) insights.

article thumbnail

The Workforce Now Spans 5 Generations — How Can You Meet Everyone’s Needs?

Salesforce

Is age part of your equation when you think about diversity, equity and inclusion? It should be, especially now with five generations currently in the workplace. Companies need to meet the needs of this intergenerational workforce, and those that do see a positive impact from age diversity and age-friendly workplaces. According to an AARP survey of corporate executives , 83% reported that a multigenerational workforce was valuable to their organizations’ success and growth.

article thumbnail

Cognito Therapeutics Announces Proprietary Gamma Sensory Stimulation for 6-Months Reduces White Matter Atrophy in Alzheimer’s Disease Patients

Legacy MEDSearch

Cognito Therapeutics , announced that its proprietary gamma sensory stimulation at 40Hz over a 6-month period reduced white matter atrophy in the brain for patients with Alzheimer’s Disease, according to new data presented at the Alzheimer’s Association International Conference 2022. Alzheimer’s Disease (AD) is the most common form of dementia. Although white matter atrophy is observed in normal aging, it is more pronounced in AD patients.

article thumbnail

Most people with opioid use disorder don’t get meds for it, but these 3 changes could help

MedCity News

Medications that treat opioid use disorder (OUD) — such as methadone, buprenorphine and extended-release naltrexone — are proven to save lives. However, a new study revealed that less than 15% of Americans with OUD receive these medications. Its lead author laid out three actions the U.S. should prioritize to increase access.

Medical 117
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Vaccine Administration: The Growing Role of Prefilled Syringes

PharmaTech

The option of using prefilled syringes for vaccinations is not (yet) available for all types of vaccines. Stakeholders are working to expand that option while also pursuing other non-traditional routes of administration.

98
article thumbnail

The Complete Field Guide For Solar Sales Leaders

Spotio

The Complete Guide for Solar Sales Leaders. SPOTIO has been helping solar field sales take their teams to the next level and achieve more since 2014. Today, we work with hundreds of residential and commercial solar companies worldwide. From our unique position, we’ve been able to distill down the best tips, tricks, and benchmark performance data to help the entire industry overcome today’s challenges and continue to thrive in the future.

Sales 98
article thumbnail

Flexible Work Demands New Skills of Leaders

Salesforce

If the number of new management books , conferences , and executive education programs are any indication, senior leaders and team managers are going to need a whole new set of skills to succeed in the new model of company culture — flexible work. . Surveys show that employees want, and employers will oblige, flexible work arrangements where employees work in the office only part of the time.

article thumbnail

NYC Health + Hospitals adds mental health services to virtual urgent care platform with $3.9 grant

MedCity News

NYC Health + Hospitals recently received a $3.9 million grant from Helmsley Charitable Trust to incorporate mental health services into ExpressCare, the health system’s virtual urgent care platform. The health system will also launch a version of its new tele-behavioral health services that is tailored to the New York City’s homeless residents.

117
117
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

AbbVie reports 4.5% rise in Q2 2022 net revenues

Pharmaceutical Technology

AbbVie has reported net revenues of $14.6bn for the second quarter (Q2) of 2022 as against $14bn in the year-ago quarter, indicating a 4.5% rise on a GAAP basis. Net revenue surged by 6.1% on an operational basis during the quarter. The GAAP diluted earnings per share (EPS) for the quarter ended 30 June grew by 21.4% to 0.51 from $0.42 in Q2 2021. An 11.2% surge in adjusted diluted EPS of $3.37 was reported in Q2 this year against $3.03 in the prior-year quarter.

Sales 98
article thumbnail

CCC and Chinese Medical Association Publishing House Partner to Provide Global Licensing Solution for CMA Articles

Copyright Clearance Center

August 2, 2022 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, has contracted with the Chinese Medical Association Publishing House (CMAPH) to offer document delivery and licensing solutions for all CMAPH journals. CMA titles will now be included in the Republication License Service on CCC Marketplace and Document Delivery with RightFind.

Medical 98
article thumbnail

Shorter timelines, evolving strategies: Four key trends in regulatory approvals of new medicines

Clarivate

A new study by the Centre for Innovation in Regulatory Science (CIRS) has shown that the approval times of major global regulatory agencies have reduced and converged over the last decade, though there are still differences between them. Increased collaboration between regulatory agencies also appears to be having a positive impact on the roll out of new drugs.

article thumbnail

Weathering the good and the bad: Why good business practices work

MedCity News

For most companies and medtech, in particular, good business practices (GBP) happens on multiple levels. On the micro level, it’s more prescriptive (i.e., regulatory best practices or good manufacturing practices). On the macro level, it’s expressed as a set of ethics and principles that govern a company’s conduct.

Ethics 117
article thumbnail

ABM Evolution: How Top Marketers Are Using Account-Based Strategies

In times of economic uncertainty, account-based strategies are essential. According to several business analysts and practitioners, ABM is a necessity for creating more predictable revenue. Research shows that nearly three-quarters of marketers (74%) already have the resources needed to build successful ABM programs.